Clinicopathologic Study of 28 Cases of Tubulocystic Renal Cell Carcinoma: Is It Time to Reclassify It as a Tubulocystic Renal Cell Tumor?
2024

Study of Tubulocystic Renal Cell Carcinoma Cases

Sample size: 28 publication Evidence: low

Author Information

Author(s): Muacevic Alexander, Adler John R, Xiao Guang-Qian, Karne Vidyadhari, Phan Stephen, Cuber Alicia, Chiu Richard, Wallace William D

Primary Institution: University of Southern California Keck School of Medicine

Hypothesis

Is it time to reclassify tubulocystic renal cell carcinoma as a tubulocystic renal cell tumor?

Conclusion

The study suggests reclassifying tubulocystic renal cell carcinoma as a tubulocystic renal cell tumor due to its indolent behavior and association with end-stage kidney disease.

Supporting Evidence

  • The tumor had a male predominance.
  • Tumor size ranged from 0.1 cm to 3.5 cm.
  • Multifocality and peripheral location were common.
  • More than 1/3rd of the cases presented with pseudoinvasion into fat.
  • 54% of cases concurred with papillary adenoma(s).
  • 96% of cases displayed end-stage kidney disease.

Takeaway

This study looked at 28 cases of a rare kidney tumor and found that it usually behaves in a harmless way, so it might be better to call it a different type of tumor.

Methodology

The study reviewed 28 cases of tubulocystic renal cell carcinoma for clinicopathological features and immunohistochemistry.

Limitations

The study is limited by a small sample size and lack of robust clinical and molecular data.

Participant Demographics

Patients' ages ranged from 23 to 85 years, with a male-to-female ratio of 8:1.

Digital Object Identifier (DOI)

10.7759/cureus.74015

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication